Patient Information Leaflet
BiResp Spiromax 320320 micrograms/9 micrograms powder for inhalation
budesonida/formoterol fumarato dihidrato
Read this leaflet carefully before you start using this medicine, because it contains important information for you.
-This medicine has been prescribed for you only, and you must not give it to others even if they have the same symptoms as you, as it may harm them.
1.What BiResp Spiromax is and what it is used for
2.What you need to know before you start using BiResp Spiromax
3.How to use BiResp Spiromax
4.Possible side effects
5.Storage of BiResp Spiromax
6.Contents of the pack and additional information
BiResp Spiromax contains two distinct active principles: budesonide and formoterol fumarate dihydrate.
BiResp Spiromax is indicated for use only in adults and adolescents 12 years of age and older.
Your doctor has prescribed this medication as treatment for asthma or chronic obstructive pulmonary disease (COPD).
Asthma
If used to treat asthma, your doctor will prescribe BiResp Spiromax along with an additional “reliever” inhaler, such as salbutamol.
Do not use BiResp Spiromax 320/9 micrograms as a “reliever” inhaler.
Chronic Obstructive Pulmonary Disease (COPD)
COPD is a long-term disease that affects the respiratory airways of the lungs, often caused by smoking cigarettes. Some of its symptoms include difficulty breathing, coughing, chest discomfort, and mucus production. BiResp Spiromax can also be used to treat severe COPD symptoms in adults only.
Do not use BiResp Spiromax
If you are allergic to budesonide, formoterol fumarate dihydrate, or any other component of this medication (including those listed in section6).
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take BiResp Spiromax if
If you have been taking steroid tablets for asthma or COPD, your doctor may reduce the number of tablets when you start using BiResp Spiromax. If you have been taking steroid tablets for a long time, your doctor may want to do regular blood tests. Reducing the number of steroid tablets may make you feel generally unwell even though your chest symptoms improve. You may notice symptoms such as a blocked nose or runny nose, weakness, joint or muscle pain, or a rash (eczema). If you are bothered by any of these symptoms or if you notice symptoms such as headache, tiredness, nausea (stomach upset), or vomiting (bringing up), call your doctorimmediately. You may need to take other medicines if you start to have allergy or arthritis symptoms. Talk to your doctor if you are unsure whether to continue using BiResp Spiromax.
Your doctor may consider adding steroid tablets to your usual treatment if you have a condition such as a chest infection or before an operation.
Contact your doctor if you experience blurred vision or other visual disturbances.
Children
Do not administer this medication to children under 12years.
Using BiResp Spiromax with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Particularly, inform your doctor or pharmacist if you are taking any of the following medications:
Some medications may increase the effects of BiResp Spiromax, so your doctor will do thorough checks if you are taking these medications (including some for HIV: ritonavir, cobicistat).
If you are in any of these situations or are unsure, talk to your doctor, pharmacist, or nurse before using BiResp Spiromax.
Also inform your doctor, pharmacist, or nurse if you are to undergo general anesthesia for an operation or dental treatment, in order to contribute to minimizing any risk of interaction with the anesthetic you will receive.
Pregnancy and breastfeeding
Driving and operating machinery
It is unlikely that BiResp Spiromax will affect your ability to drive or use tools or machines.
BiResp Spiromax contains lactose
Lactose is a type of sugar found in milk. If your doctor has told you that you have a problem with certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor, pharmacist, or nurse again.
Asthma
Use BiResp Spiromaxevery day.This helps to prevent asthma symptoms from appearing.
Recommended dose:
Adults (18 years and older)
1 inhalation (application) twice a day, administered in the morning and at night.
Your doctor may increase the dose up to 2 inhalations twice a day.
If your symptoms are well-controlled, your doctor may ask you to use this medicine once a day.
Adolescents (12 years and older)
1 inhalation twice a day.
Your doctor will help you control your asthma and adjust the dose of this medication to the lowest possible to control your asthma. If your doctor believes you need a lower dose than what is available in your BiResp Spiromax, your doctor may prescribe an alternative inhaler containing the same active ingredients as your BiResp Spiromax, but with a lower dose of corticosteroid.If your symptoms are well-controlled, your doctor may ask you to use this medicine once a day. However, do not adjust the number of inhalations your doctor has prescribed without speaking to them first.
Use the other "relief inhaler" to treat asthma symptoms when they appear.
Always carry the "relief inhaler" with you and use it to relieve sudden attacks of difficulty breathing and wheezing (chest whistling sounds). Do not use BiResp Spiromax to treat these asthma symptoms.It is essential to discuss with your doctor the use of BiResp Spiromax to prevent asthma symptoms; the frequency of exercise or exposure to allergens may have implications for the treatment you have been prescribed.
Chronic Obstructive Pulmonary Disease (COPD)
Recommended dose:
Adults (18 years and older) only:
Your doctor may also prescribe another bronchodilator medication, such as an anticholinergic (such as tiotropium or ipratropium bromide), for your COPD.
Preparing your new BiResp Spiromax
Before using your new BiResp Spiromax inhaler for the first time, you must prepare it as follows:
How to perform an inhalation
Each time you need to make an inhalation, follow the instructions below:
1. Hold the inhalerwith the semi-transparent red wine-colored mouthpiece facing downwards
4.Place the mouthpiece between your teeth. Do not bite the mouthpiece. Close your lips around the mouthpiece. Be careful not to block the air intakes.
Inhale as deeply and strongly as possible through your mouth.
5.Remove the inhaler from your mouth. You may notice a taste when performing the inhalation.
6.Hold your breath for 10 seconds or as long as you can without discomfort.
7.Then, exhale slowly(but do not exhale through the inhaler). Close the mouthpiece cover.
If you are going to make a second inhalation, repeat steps 1 to 7.
Rinse your mouth with water after each dose and spit it out.
Do not attempt to disassemble the inhaler or remove or twist the mouthpiece cover, as it is fixed to the inhaler and should not come loose. Do not use the Spiromax if it is damaged or if the mouthpiece has come loose from the Spiromax. Do not open or close the mouthpiece cover unless you are going to use the inhaler.
Cleaning the Spiromax
Keep the Spiromax dry and clean.
If necessary, wipe the mouthpiece of the Spiromax with a dry cloth or tissue after use.
When to start using a new Spiromax
Note:
Important information about asthma or COPD symptoms
If you notice that you are short of breath or have wheezing during the use of BiResp Spiromax, you should continue to use it, but see your doctor as soon as possible, as you may need additional treatment.
Contact your doctorimmediatelyif:
These signs may indicate that your asthma or COPD is not being properly controlled and that you may needimmediatelydifferent or additional treatment.
Once your asthma is controlled, your doctor may consider reducing the dose of BiResp Spiromax gradually.
If you use more BiResp Spiromaxthan you should
It is essential to take the dose your doctor has prescribed. Do not exceed the dose prescribed without consulting your doctor.
If you use more BiResp Spiromax than you should, consult your doctor, pharmacist, or nurse.
The most common symptoms that may occur when you use more BiResp Spiromax than you should are shakiness, headache, or rapid heartbeat.
If you forgot to use BiResp Spiromax
If you forgot to take a dose, take it as soon as you remember. However,do nottake a double dose to compensate for the missed doses. If it is almost time for your next dose, simply take the next dose at the usual time.
If you notice that you are wheezing or short of breath, or if you notice any other symptoms of an asthma attack,use your "relief inhaler"and see your doctor.
If you interrupt treatment with BiResp Spiromax
Do not stop using the inhaler without speaking to your doctor first.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you notice any of the following symptoms, stop using BiResp Spiromaxandconsult your doctor immediately:
Rare side effects: may affect up to 1 in 1,000 peoplepeople
Very rare side effects: may affect up to 1 in 10,000 peoplepeople
Other possible side effects:
Frequent: may affect up to 1 in 10 peoplepeople
Inform your doctor if you have any of the following symptoms while inhalingBiResp Spiromax, they may be symptoms of a lung infection:
Uncommon: may affect up to 1 in 100 peoplepeople
Rare:
Very rare:
Inhaled corticosteroids can affect the normal production of steroid hormones in the body, especially if used in high doses for prolonged periods. Among their effects are:
These effects occur very rarely and are much less likely to occur with inhaled corticosteroids than with oral tablets.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the national notification system included in theAppendixV. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Composition of BiResp Spiromax
Appearance of BiResp Spiromax and contents of the package
BiResp Spiromax is a powder for inhalation.
Each BiResp Spiromax inhaler contains 60 inhalations and is white in color, with a semi-transparent red wine-colored cap for the mouthpiece.
Packaging of 1, 2, and 3 inhalers. Only some package sizes may be marketed in your country.
Marketing Authorization Holder
Teva Pharma B.V.,
Swensweg 5, 2031 GA Haarlem, Netherlands.
Responsible for manufacturing
Norton (Waterford) Limited T/A Teva Pharmaceuticals Ireland
Unit 27/35, IDA Industrial Park, Cork Road, Waterford, Ireland
Teva Pharmaceuticals Europe B.V., Swensweg 5, 2031 GA Haarlem, Netherlands
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Belgium/Belgique/Belgien Teva Pharma Belgium N.V./S.A./AG Tel/Tél: +32 3 820 73 73 | Luxembourg/Luxemburg Teva Pharma Belgium N.V./S.A./AG Belgium/Belgien Tel/Tél: +32 3 820 73 73 |
Bulgaria Teva Pharmaceuticals Bulgaria EOOD Tel: +359 2 489 95 85 | Hungary Teva Gyógyszergyár Zrt Tel.: +36 1 288 64 00 |
Czech Republic Teva Pharmaceuticals CR, s.r.o. Tel: +420 251 007 111 | Malta Teva Pharmaceuticals Ireland Ireland Tel:+44 207 540 7117 |
Danmark Teva Denmark A/S Tlf: +45 44 98 55 11 | Netherlands Teva Nederland B.V. Tel: +31 800 0228 400 |
Deutschland Teva GmbH Tel: +49 731 402 08 | Norway Teva Norway AS Tlf: +47 6677 55 90 |
Eesti UAB Teva BalticsEesti filiaal Tel: +372 661 0801 | Austria ratiopharm Arzneimittel Vertriebs GmbH Tel: +43 1 97007 0 |
Ελλάδα Specifar A.B.E.E Τηλ: +30 211 880 5000 | Poland Teva Pharmaceuticals Polska Sp. z o.o. Tel.: +48 22 345 93 00 |
Spain Laboratorios BIAL, S.A. Tel.: +34915624196 | Portugal Teva Pharma - Produtos Farmacêuticos Lda Tel: +351 21 476 75 50 |
France Teva Santé Tél: +33 1 55 91 7800 | Romania Teva Pharmaceuticals S.R.L Tel: +4021 230 6524 |
Ireland Teva Pharmaceuticals Ireland Tel:+44 207 540 7117 | Slovenia Pliva Ljubljana d.o.o. Tel: +386 1 58 90 390 |
Ísland Alvogen ehf. Sími: + 354 522 2900 | Slovakia Teva Pharmaceuticals Slovakia s.r.o. Tel: +421 2 5726 7911 |
Italy Teva Italia S.r.l. Tel: +39 028 917 981 | Finland Teva Finland Oy Puh/Tel: +358 20 180 5900 |
Κύπρος Specifar A.B.E.E. Ελλάδα Τηλ: +30 211 880 5000 | Sweden Teva Sweden AB Tel: +46 42 12 11 00 |
Lithuania UABTeva Baltics Tel: +370 5 266 02 03 | United Kingdom(Northern Ireland) Teva Pharmaceuticals Ireland Ireland Tel: +44 207 540 7117 |
Latvia UABTeva Baltics Tel: +371 67 323 666 | Croatia Pliva Hrvatska d.o.o Tel: + 385 1 37 20 000 |
Last review date of this leaflet:May 2021
Other sources of information
The detailed information about this medication is available on the website of the European Medicines Agency:http://www.ema.europa.eu.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.